Search research articles
Contact Us
Filters
Showing results (31-40 of 203) with videos related to
Page
of 21
Sort By:
Infection and Immunity
|
August 1, 1992
Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors
R H See, A W Chow
Infectious Disease Clinics of North America
|
March 1, 1988
Normal flora and mucosal immunity of the head and neck
D L Roscoe, A W Chow
Infectious Disease Clinics of North America
|
December 1, 1999
Oral complications associated with immunosuppression and cancer therapies
J B Epstein, A W Chow
Canadian Medical Association Journal
|
May 1, 1983
Dealing with the misuse of antibiotics in the hospital
P J Jewesson, A W Chow
The Journal of Infectious Diseases
|
May 24, 2001
Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1
W W Kum, A W Chow
Medicine
|
March 1, 1974
Bacteroidaceae bacteremia: clinical experience with 112 patients
A W Chow, L B Guze
Annals of Internal Medicine
|
November 1, 1971
More on antibiotic susceptibility of Bacteriodes
A W Chow, L B Guze
Infection Control and Hospital Epidemiology
|
May 1, 1991
Epidemiologic typing systems for coagulase-negative staphylococci
D Birnbaum, M Kelly, A W Chow
Antimicrobial Agents and Chemotherapy
|
January 1, 1970
Cytosine arabinoside therapy for herpesvirus infections
A W Chow, J Foerster, W Hryniuk
Antimicrobial Agents and Chemotherapy
|
March 1, 1978
Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents
A W Chow, V Patten, D Bednorz
Page
of 21
Search research articles
Search
Showing results (31-40 of 203) with videos related to
Sort By:
Page
of 21
Infection and Immunity
|
August 1, 1992
Staphylococcal toxic shock syndrome toxin 1-induced tumor necrosis factor alpha and interleukin-1 beta secretion by human peripheral blood monocytes and T lymphocytes is differentially suppressed by protein kinase inhibitors
R H See, A W Chow
Infectious Disease Clinics of North America
|
March 1, 1988
Normal flora and mucosal immunity of the head and neck
D L Roscoe, A W Chow
Infectious Disease Clinics of North America
|
December 1, 1999
Oral complications associated with immunosuppression and cancer therapies
J B Epstein, A W Chow
Canadian Medical Association Journal
|
May 1, 1983
Dealing with the misuse of antibiotics in the hospital
P J Jewesson, A W Chow
The Journal of Infectious Diseases
|
May 24, 2001
Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1
W W Kum, A W Chow
Medicine
|
March 1, 1974
Bacteroidaceae bacteremia: clinical experience with 112 patients
A W Chow, L B Guze
Annals of Internal Medicine
|
November 1, 1971
More on antibiotic susceptibility of Bacteriodes
A W Chow, L B Guze
Infection Control and Hospital Epidemiology
|
May 1, 1991
Epidemiologic typing systems for coagulase-negative staphylococci
D Birnbaum, M Kelly, A W Chow
Antimicrobial Agents and Chemotherapy
|
January 1, 1970
Cytosine arabinoside therapy for herpesvirus infections
A W Chow, J Foerster, W Hryniuk
Antimicrobial Agents and Chemotherapy
|
March 1, 1978
Susceptibility of Campylobacter fetus to twenty-two antimicrobial agents
A W Chow, V Patten, D Bednorz
Page
of 21